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Although more than 1,500 mutations and polymorphisms have been reported within
the cystic ﬁbrosis (CF) transmembrane conductance regulator (CFTR) gene, the
genetic basis of the disease remain obscure in some CF patients. Moreover, it
has been suggested that other genes may be involved in the pathogenesis of the
disease. A cohort of unambigously characterized CF patients (n = 16), who carry
at least one CFTR mutation-negative allele after the complete scanning by modern,
potent techniques, was investigated by alternative strategies: quantitative multiplex
PCR of short ﬂuorescent fragments (QMPSF) of evolutionarily conserved regions
(ECRs) within both the distal CFTR promoter and introns, as well as sequencing of
CFTR 3′-UTR and the epithelial Na+ channel (ENaC) subunit-encoding sequences.
QMPSF analysis and sequencing revealed a speciﬁc, atypical haplotype that may
be associated to the genetic defect in one patient. While a total of two and thirteen
polymorphisms were respectively identiﬁed within the CFTR 3′-UTR and ENaC-
encoding genes, major disease-causing mutations could not be detected in the other
patients. In spite of an extensive analysis of the CF chromosomes in our cohort,
genetic factors of the disease in these subjects remain to be found and additional
studies must be carried out. Nevertheless, our strategy may have applications for
the study of both distal promoter and intronic variations in numerous genes.
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To date, about 1500 mutations have been found within human CFTR sequence.
These mutations could be classiﬁed according to their degree of severity in CF
disease (severe, mild or polymorphic). While the most common mutations (F508del
and the 30 mutations routinely screened in CF patients), are well characterized, few
data are available for rarer mutations. So genetic counseling is particularly difﬁcult
when fetuses or CF patients present these orphan variations. We have developed in
vitro biology assays to characterize mutation impact upon CFTR maturation process,
trafﬁcking and activity in order to establish a genotype/phenotype correlation. We
present here our results obtained with seven rare mutations which have been isolated
in our lab.
We have used a GFP-tagged CFTR construct to generate these mutations by site-
directed mutagenesis. Each plasmid was transfected in COS-7 cells to express the
mutated proteins. We visualized CFTR trafﬁcking by confocal microscopy and its
cellular localization was determined using several markers. By western blot, we
studied CFTR maturation process by quantifying the relative amount of mature and
non mature CFTR (C and B bands). We evaluated CFTR channel activity by efﬂux
assays, using notably pharmacoperones (MPBs or Miglustat).
Our results indicate a clear physiopathological effect of the studied CFTR mutations
(retainment in ER, abnormal maturation, null CFTR activity). These data, in
relation with clinical survey of the patients should be useful for genetic counseling.
Moreover, this work could contribute to the improvement of pharmacological studies
of CFTR mutations. In conclusion, we recommend that each new or orphan CFTR
mutation is subjected to this type of study.
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Background: CF and CFTR-related disorders are mainly due to point mutations
scattered over the whole CFTR gene. Search for large CFTR rearrangements
using semi-quantitative ﬂuorescent multiplex (QFM) PCR assays is now part of
the molecular diagnosis and allows to identify 2% of CF alleles. Rearrangements
mainly comprise single or multiple exon deletions; duplications are rare and are
indeed more difﬁcult to detect and characterize. Of the four CFTR duplications
reported, three were detected in our laboratory by QFM-PCR, in two CF patients
and a CBAVD patient. They involved exons 4−8, 10−18 and 11−13, respectively,
in trans of another CFTR mutation.
Methods: The duplications were characterized by using a combination of long-
range (LR) PCR, digestion of LR-PCR products and sequencing.
Results: Two duplications were fully characterized, in direct tandem each: dup10_18
(~70kb long), and dup11_13 (~17kb long). Characterization of the remaining
dup4_8 is in process. However, given the classical CF phenotype of the patient,
we hypothesize that the duplicated region is located inside the CFTR gene and
interferes with the transcription, translation or maturation process, thus resulting in
a null mutation.
Conclusion: Effective tools are required to detect duplications, which may indeed
be under-diagnosed. Reﬁnement of the breakpoints is important to conﬁrm a
deleterious effect and should contribute to understand the duplication mechanism.
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Chronic sinusitis invariably affects Cystic Fibrosis (CF) patients. Certain genotypes
may be more likely associated with sinus symptoms and the main allele was F508del
(76%) (Jorissen MB 1999 Am J Resp Crit Care Med 159:1412).
We reported a case of eleven-year-old girl, from South of France, with digital hip-
pocratism, presenting in childhood pansinusitis with Pneumococcus lung infection,
episodes of asthma and a borderline elevated sweat test (56mmol/l). The CFTR
gene was entirely screened for mutations by DGGE-sequencing of all exons and
ﬂanking intronic regions. The genotype associated two missense CFTR mutations
in the NBF1 region, namely: (i) 1687A>G (S519G exon 10), once reported in
a non CF patient, and (ii) 1859G>C (G576A exon 12) previously considered as
a neutral polymorphism, later detected in classical CF, likely to affect the CFTR
mRNA, lacking exon 12 (Pagani F. Hum Mol Genet 2003; 12,10: 1111), found in
cis on the paternal allele; (infertile biological father needed in vitro fecundation).
Five additionnal polymorphisms were found: 3 intronic, namely (GATT)6/(GATT)7,
IVS6a, 1001+11C>T, IVS6b, and (TG)10T9/(TG)10T7, IVS8, 2 exonic, 2694T>G
(T854T exon 14a) and 4521G>A (Q1463Q exon 24) at heterozygous state. The
470V was not present.
Previously reported, CF carrier status might predispose to chronic sinusitis without
nasal polyps (Wang XJ 2000 JAMA 11;284:1814). Although greater series of CF
with pansinusitis would be necessary to verify these clinical symptoms-mutations-
polymorphisms associations, that constitutes an approach in genotype-phenotype
relation in such mild CF disease with chronic rhinosinusitis.
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